Mahamaya Lifesciences Ltd Share Price History
Mahamaya Lifesciences Ltd
BSE : 23 Jan, 2026
164.953.5 (2.1%)
Prev Close
161.5
Open Price
159.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
15600
Today's High / Low
166.9 / 156.0
52 WK High / Low
205.1 / 111.0
Market Price of Mahamaya Lifesciences Ltd
1M
1Y
3Y
5Y
Monitoring Mahamaya Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 21.81 |
| YoY Gr. | - |
| Net Profit (Cr.) | 3 |
| BVPS | 125.77 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 15.2 |
| Op. Profit Mgn % | 7.02 |
| Net Profit Mgn % | 3.03 |
| Debt to Equity % | 1.22 |
Latest Shareholding
Promoters Holdings Over Time
About Mahamaya Lifesciences Ltd
- Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
- Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
- The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
- The Company began the journey by focusing on import and registration of vital pesticide molecules.
- It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.
Popular Search
FAQs for Mahamaya Lifesciences Ltd Share Price History
What are the key events that typically impact Mahamaya Lifesciences Ltd's share price history?
Key events that impact Mahamaya Lifesciences Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Mahamaya Lifesciences Ltd's share price history?
Stock splits reduce the nominal price of Mahamaya Lifesciences Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Mahamaya Lifesciences Ltd?
Dividends can influence Mahamaya Lifesciences Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Mahamaya Lifesciences Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Mahamaya Lifesciences Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Mahamaya Lifesciences Ltd’s share price history?
To understand Mahamaya Lifesciences Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
